Precigen, INC Form 4 insider transactions

Precigen Director Steven Frank converted 71,839 restricted stock units into common stock, increasing his direct ownership.

Precigen Director Vinita D. Gupta converted 71,839 restricted stock units into common stock, increasing her direct beneficial ownership.

Precigen Director Fred Hassan converted 71,839 Restricted Stock Units into common stock, increasing his direct beneficial ownership to 1,243,239 shares.

Precigen Director Jeffrey B. Kindler converted 71,839 restricted stock units into common stock, increasing his direct beneficial ownership to 202,100 shares.

Precigen Director James S. Turley acquired 71,839 shares of common stock on March 13, 2026, through the vesting of restricted stock units.

Precigen Director and 10% owner Randal J. Kirk acquired additional common stock, restricted stock units, and stock options, increasing his beneficial ownership.

Precigen Director James S. Turley acquired common stock, restricted stock units, and stock options on March 10, 2026, increasing his beneficial ownership.

Precigen Director Jeffrey B. Kindler acquired common stock, restricted stock units, and stock options as part of his compensation.

Precigen Director Fred Hassan received common stock, restricted stock units, and stock options as part of his annual compensation package, aligning his interests with shareholders.

Precigen Director Vinita D. Gupta acquired common stock, restricted stock units, and stock options on March 10, 2026, increasing her beneficial ownership.

Precigen Director Steven Frank acquired common stock, restricted stock units, and stock options as part of his compensation.

Precigen Director Cesar L. Alvarez acquired common stock, restricted stock units, and stock options on March 10, 2026, increasing his beneficial ownership.

Precigen Director Nancy H. Agee acquired common stock, restricted stock units, and stock options as part of her compensation on March 10, 2026.

Precigen's Director and 10% owner, Randal J. Kirk, reported the sale of nearly 2 million shares of common stock for approximately $8.3 million.

Jeffrey B. Kindler, a director at Precigen, Inc., sold 235,467 shares of common stock for a weighted average price of $3.6349 per share.

Randal J. Kirk, a Director and 10% owner of Precigen, Inc., reported selling over 2.9 million shares of common stock across three transactions in November 2025.

Jeffrey B. Kindler, a Director at Precigen, Inc., sold 174,360 shares of common stock for over $600,000 through pre-scheduled transactions.

Precigen Director and 10% owner Randal J. Kirk reported the direct sale of 1,809,667 shares of common stock at a weighted average price of $3.41.

Precigen's Chief Operating Officer, Rutul R. Shah, acquired 2,000 shares of common stock at $3.40 per share, increasing his beneficial ownership to 405,959 shares.

Precigen's Chief Commercial Officer, Phil Tennant, acquired 6,000 shares of common stock at $3.58 per share, increasing his direct beneficial ownership to 65,031 shares.

Precigen's Chief Financial Officer, Harry Thomasian Jr., reported increasing his direct beneficial ownership of common stock through recent open market purchases.

Precigen Director and 10% owner Randal J. Kirk reported the conversion of preferred stock into common shares and subsequent sales totaling over $18.6 million through controlled entities.

Precigen's President and CEO, Helen Sabzevari, vested 825,000 performance stock units, representing the second installment of a grant from August 2024.

Precigen's Chief Financial Officer, Harry Thomasian Jr., vested 125,000 performance stock units, convertible into common stock or cash, on September 12, 2025.

Donald P. Lehr, Chief Legal Officer of Precigen, Inc., vested 54,000 performance stock units, convertible into common stock or cash, after meeting applicable performance conditions.

Precigen's Chief Commercial Officer, Phil Tennant, acquired 25,000 performance stock units following the vesting of a second installment.

Precigen's Chief Operating Officer, Rutul R. Shah, saw 125,000 performance stock units vest, convertible into common stock or cash.

Precigen, Inc. Director Nancy H. Agee acquired 15,000 shares of common stock at $4.60 per share.

Precigen Director Nancy H. Agee acquired additional common stock in two separate transactions in August 2025, increasing her beneficial ownership.

Precigen, Inc. Director Nancy H. Agee converted 126,760 restricted stock units into common stock on July 5, 2025, increasing her direct beneficial ownership to 176,836 shares.